Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Area of Science:

• Immunology
• Computational Biology
• Bioinformatics

Background:

• In silico modeling of MHC class I peptide binding has evolved over the past decade.
• Historically, reliable modeling was limited to a few human or mouse histocompatibility molecules.

Purpose of the Study:

• To review the advancements in in silico models for MHC class I peptide binding.
• To highlight useful and historically important prediction methods.
• To showcase the application of these 'reverse immunology' systems in epitope discovery.

Main Methods:

• Explanation of various in silico prediction methods for peptide-MHC binding.
• Review of case studies demonstrating the use of these systems in epitope discovery.

Main Results:

• High-accuracy predictions are now available for Human Leukocyte Antigen (HLA)-A and -B molecules.
• Peptide binding can be predicted for MHC molecules from non-human primates, mice, and other mammals.
• In silico models have become highly efficient tools for epitope discovery.

Conclusions:

• The new generation of in silico epitope discovery systems represents a significant advancement.
• These advanced models offer high accuracy and broad applicability across species.
• Outdated and less accurate prediction systems are now obsolete and should be abandoned.